Sinovac Biotech Ltd.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 72,524 49,216 56,842 33,401
Cost of Revenue 21,273 19,100 21,128 16,719
Gross Profit 51,251 30,116 35,714 16,683
Operating Expenses
Research and Development 8,384 17,044 9,007 8,508
Sales, General and Admin. 34,538 32,907 23,045 16,961
Non-Recurring Items (416) 1,316 288 3,159
Other - - - 1,411
Operating Income 8,745 (21,151) 3,374 (13,356)
Income From Continuing Operations
Add'l Income/Expense Items 2,431 2,293 1,677 1,229
Earnings Before Interest and Tax 11,176 (18,858) 5,051 (12,128)
Interest Expense 3,031 775 384 1,178
Earnings Before Tax 8,145 (19,633) 4,667 (13,306)
Income Tax (2,225) (884) 5,066 (704)
Minority Interest 2,928 (3,896) 445 (4,095)
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 7,442 (14,853) (844) (8,507)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 7,442 (14,853) (844) (8,507)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 7,442 (14,853) (844) (8,507)